Literature DB >> 16639361

The hypothalamic control of bone mass, implication for the treatment of osteoporosis.

G Karsenty1, P Ducy.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16639361     DOI: 10.1016/s0003-4266(06)72566-5

Source DB:  PubMed          Journal:  Ann Endocrinol (Paris)        ISSN: 0003-4266            Impact factor:   2.478


× No keyword cloud information.
  5 in total

1.  Possible mechanisms for the skeletal effects of antipsychotics in children and adolescents.

Authors:  Chadi A Calarge; Stephanie D Ivins; Katherine J Motyl; Amal A Shibli-Rahhal; Michael M Bliziotes; Janet A Schlechte
Journal:  Ther Adv Psychopharmacol       Date:  2013-10

Review 2.  Aromatase inhibitor-associated bone loss: clinical considerations.

Authors:  Shubham Pant; Charles L Shapiro
Journal:  Drugs       Date:  2008       Impact factor: 9.546

3.  A bone-protective role for IL-17 receptor signaling in ovariectomy-induced bone loss.

Authors:  Jaya Goswami; Nydiaris Hernández-Santos; Luis A Zuniga; Sarah L Gaffen
Journal:  Eur J Immunol       Date:  2009-10       Impact factor: 5.532

4.  Osteoblast-specific expression of the fibrous dysplasia (FD)-causing mutation Gsα(R201C) produces a high bone mass phenotype but does not reproduce FD in the mouse.

Authors:  Cristina Remoli; Stefano Michienzi; Benedetto Sacchetti; Alberto Di Consiglio; Stefania Cersosimo; Emanuela Spica; Pamela G Robey; Kenn Holmbeck; Ana Cumano; Alan Boyde; Graham Davis; Isabella Saggio; Mara Riminucci; Paolo Bianco
Journal:  J Bone Miner Res       Date:  2015-06       Impact factor: 6.741

5.  Female Mice Lacking Estrogen Receptor-α in Hypothalamic Proopiomelanocortin (POMC) Neurons Display Enhanced Estrogenic Response on Cortical Bone Mass.

Authors:  H H Farman; S H Windahl; L Westberg; H Isaksson; E Egecioglu; E Schele; H Ryberg; J O Jansson; J Tuukkanen; A Koskela; S K Xie; L Hahner; J Zehr; D J Clegg; M K Lagerquist; C Ohlsson
Journal:  Endocrinology       Date:  2016-06-02       Impact factor: 4.736

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.